Advertisement

Topics

Regeneron And Sanofi Antibody Discovery Deal To End

08:12 EDT 4 Aug 2017 | SCRIP

Regeneron and Sanofi have decided to call it a day on their antibody discovery partnership that brought the world Praluent...

      

Related Stories

 

Original Article: Regeneron And Sanofi Antibody Discovery Deal To End

NEXT ARTICLE

More From BioPortfolio on "Regeneron And Sanofi Antibody Discovery Deal To End"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...